Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Journeo stock jumps after CFDS buyout: What it means for transport and defence tech Journeo acquires CFDS for £13.7M to expand into UK critical infrastructure protection. Find out what this means for its £100M revenue ambition. byPallavi MadhirajuSeptember 2, 2025